Introduction
Retroviruses induce disease in susceptible hosts via insertional mutagenesis of cellular proto-oncogenes or tumor suppressor genes (Ihle et al., 1990; Peters, 1990; van Lohuizen and Berns, 1990; Berns, 1991) . The disease genes that are aected by viral integration can thus be identi®ed as common sites of retroviral integration in tumor DNAs. One set of mouse strains that has proven particularly valuable for the study of retrovirally induced leukemias is the AKXD recombinant inbred (RI) strains (Mucenski et al., 1986; Gilbert et al., 1993) . The 21 AKXD strains were derived by crossing mice from two inbred mouse strains that dier in their lymphoma incidences, AKR/ J and DBA/2J. AKR/J is the prototypic highly lymphomatous inbred mouse strain; nearly all of these animals develop T-cell lymphomas by 7 to 16 months of age. DBA/2J is a strain with a low incidence of lymphoma. Among 21 highly lymphomatous AKXD strains available for study, only six strains die predominantly of T-cell tumors, like the AKR/J parent (Gilbert et al., 1993) . In contrast, seven strains die predominantly of B-cell tumors, one dies predominantly of myeloid tumors and seven die of a mixture of T-and B-cell tumors (Mucenski et al., 1986; Gilbert et al., 1993) .
A common viral integration site that has been identi®ed in AKXD lymphomas is Evi5 (Liao et al., 1995a) . Among 283 AKXD T-cell, B-cell, and myeloid tumors screened for Evi5 rearrangements, ten tumors showed rearrangements. All but one of these tumors was a T-cell lymphoma. These results suggest that Evi5 encodes a gene primarily involved in T-cell disease. Subsequent mapping studies localized Evi5 to mouse chromosome 5 approximately 18 kb upstream of another common viral integration site, G®1 (Liao et al., 1995a) . G®1 was identi®ed as a common viral integration site during progression of Moloney murine leukemia virus (MuLV)-induced rat interleukin-2 (IL-2)-dependent T-cell lymphoma lines to IL-2-independent growth (Gilks et al., 1993) . Proviral integration at G®1 upregulates the expression of a novel zinc ®nger protein that is expressed at low levels in IL-2-dependent T-cell lymphoma lines. Studies in mitogenstimulated splenocytes suggests that G®1 is a downstream target of the IL-2 receptor and functions during the transition from the G 1 to the S phase of the cell cycle. Consistent with this hypothesis, overexpression of G®1 does not induce expression of IL-2 but does contribute to the emergence of the IL-2-independent phenotype (Gilks et al., 1993) .
Like Evi5, G®1 is also a common viral integration site in AKXD lymphomas. Among 283 tumors analysed, 14 had G®1 rearrangements and 12 were T-cell lymphomas (Liao et al., 1995a) . G®1 thus also appears to encode a gene that predisposes to T-cell disease in the AKXD strains. Among the tumors with G®1 rearrangements, one also carried a rearrangement at Evi5, although it was not possible to tell if these rearrangements were in the same or dierent subpopulations of tumor cells (Liao et al., 1995a) .
An important question arising from these studies is whether the Evi5 locus encodes a gene separate from G®1 that also predisposes to T-cell disease or whether viral integrations at Evi5 merely serve to upregulate expression of G®1. In studies described here, we show that the Evi5 locus does in fact encode a gene that is separate and distinct from G®1. While blast searches indicated that Evi5 is a novel gene, homologies were detected between Evi5 and a known oncogene, Tre2, as well as mammalian and yeast cell cycle regulatory proteins. Evi5 thus encodes a gene separate from G®1 that may also be involved in T-cell disease.
Results

Evi5 transcripts
To search for transcripts from the Evi5 locus Northern blots of normal adult mouse tissues were probed with genomic probes from the Evi5 locus. One probe (probe S) derived from cellular DNA located to the left of provirus 82-6 (Figure 1 ; Liao et al., 1995a) , identi®ed a 6 kb transcript in all tissues tested with the highest level of expression detected in liver (data not shown). Probe S was then used to screen a mouse liver cDNA library (Stratagene) in order to isolate cDNA clones from the Evi5 gene. A number of overlapping cDNA clones were obtained. Sequence analysis of the longest clone (CP7) indicated that it was approximately 4.5 kb in length and was derived from sequences located at the 3' end of the Evi5 gene (Figure 2 , top). To isolate more 5' clones a new cDNA library was constructed using an antisense Evi5 oligonucleotide primer for ®rst strand cDNA synthesis that was homologous to sequences located near the 5' end of CP7. One clone obtained from this library (S5A-1; Figure 2 , top) extended the Evi5 sequence to within *0.5 kb from the expected 5' end of the gene. The Evi5 5' end was then obtained by anchor-ligation mediated 5' RACE (see Materials and methods). The 5' RACE reproducibly yielded a PCR product of *450 bp, which was cloned into PCR-script (R6-1, Figure 2 , top).
The Evi5 sequence
The Evi5 sequence is shown at the bottom of Figure 2 . The sequence is 5870 nucleotides in length and predicts a short 68 bp 5' UTR, a 2427 bp open-reading-frame (ORF) and a relatively long 3375 bp 3' UTR. The ®rst ATG of the predicted ORF is located within a good Kozak translation initiation sequence (Kozak, 1986) and is preceded by an in-frame TAG stop codon at bp 51 ± 53. A canonical polyadenylation signal sequence (AAUAAA, Proudfoot and Brownlee, 1976) was not found near the 3' end of the gene, however, two overlapping alternative polyadenylation signals (AA-TAAT and AATTAA, Wickens and Stefenson, 1984) were identi®ed 18 nucleotides upstream of the polyA tail (Figure 2 , bottom). The 3' UTR contains 12 copies of the mRNA destabilizing sequence AUUUA (Figure 2, Shaw and Kamen, 1986) , suggesting that Evi5 mRNA expression may be tightly regulated.
Evi5 encodes a novel coiled-coil protein with homology to a known oncogene and cell cycle regulatory proteins BLAST searches (Devereux et al., 1984) indicated that the Evi5 gene encodes a novel protein. Searches for known protein coding motifs identi®ed four potential Nlinked glycosylation sites (aa 107, 126, 495, 685) , a potential tyrosine kinase phosphorylation site (aa 415), a potential serine protein kinase C phosphorylation site (aa 113) and several potential casein kinase II phosphorylation sites. The N-terminus of Evi5 is also rich in serine and proline residues. The region of Evi5 from amino acids 50 to 150 contains 27% serine and the region from amino acids 50 to 100 contains 10% proline residues, which represents nearly a threefold increase in the frequency of such residues when compared to the protein as a whole. A second proline rich region (13.6% proline) was also identi®ed in the Evi5 C-terminus (aa 750 ± 809). Secondary structure predictions indicated that Evi5 is a coiled-coil protein (Figure 3 ). While Evi5 encodes a novel protein, BLAST searches identi®ed a number of interesting regions of homology between Evi5 and known proteins. For example, the Nterminal region of Evi5 was found to contain a recently identi®ed 180 ± 200 amino acid domain called the tbc domain (Richardson and Zon, 1995; Figure 4) . While the function of this domain is not well de®ned, it is likely to be involved in regulating protein-protein interactions. Other genes that contain a tbc domain include Tbc1, Tre2, BUB2 and cdc16 ( Figure 4 ). Tbc1 was identi®ed in a screen for genes that are dierentially regulated during mast cell development (Richardson and Zon, 1995) . Tbc1 encodes a nuclear protein and is expressed at highest levels in hematopoietic cells, testis and kidney. Within these tissues, expression of Tbc1 is cell-and stage-speci®c suggesting that Tbc1 may play a role in the cell cycle and dierentiation of various tissues. Tre2 is a human oncogene isolated during transfection of NIH3T3 cells with human Ewing's sarcoma DNA (Nakamura et al., 1988 (Nakamura et al., , 1992 . BUB2 (Hoyt et al., 1991; Wang and Burke, 1995) and cdc16 (Chang and Nurse, 1993; Fankhauser et al., 1993) are yeast genes involved in the regulation of mitosis during the cell cycle.
The C-terminal region of Evi5 shows signi®cant homology to a number of coiled-coil proteins including several myosin heavy chain proteins and mitosin (also called CENP-F), a novel *350-kilodalton nuclear phosphoprotein involved in regulating mitotic-phase cell cycle progression (Zhu et al., 1995; Liao et al., 1995b) . Proviral integrations at the Evi5 locus are located within the coding region of the Evi5 gene Two mouse genomic lambda clones (lg2 and lg4, Figure 1 ) that span the entire Evi5 common integration site (Liao et al., 1995a) were used to determine the location and orientation of proviral integrations with respect to the Evi5 gene. An oligonucleotide probe spanning bps 2191 ± 2211 of the Evi5 cDNA hybridized to both lambda clones and mapped to the left of the proviral integrations at Evi5. Genomic sequence analysis indicated that these sequences were contained within a single exon which included the entire Evi5 3' UTR and the last 104 amino acids of the Evi5 protein (bps 2185 ± 2496; Figure 1 ). The direction of Evi5 transcription was from right to left and in the same transcriptional orientation as G®1 (Figure 1) . Two other oligonucleotide probes spanning bps 2166 ± 2184 and 2162 ± 2178 of the Evi5 cDNA failed to hybridize to either lambda clone indicating that the proviral integrations are located within a single 3' intron of the Evi5 gene. The proviral integrations at Evi5 are thus likely to disrupt normal Evi5 expression.
Evi5 is a member of a well conserved multigene family
Chromosome mapping studies using a 1 kb Evi5 3' UTR cDNA probe (bps 3421 ± 4437) or an Evi5 5' coding region probe (S5A-1 (bps 348 ± 1446), Figure 2 ) detected a single locus that mapped to mouse chromosome 5. These results are consistent with previous mapping studies which localized the Evi5 common viral integration site to chromosome 5 (Liao et al., 1995a) . However, when a more 3' coding region probe (bps 1370 ± 3548) was used for mapping two additional loci, which mapped to chromosomes 10 and 18 were detected ( Figure 5 ).
Zoo blot analysis suggests that the chromosome 10 and 18 loci represent Evi5-related genes and not pseudogenes. Hybridization of the 3' Evi5 cDNA probe to DNAs from multiple dierent species identi®ed two, and often times three, Evi5-hybridizing fragments in every species tested, indicating that all three genes are evolutionarily well conserved. ( Figure  6 ).
Evi5 is widely expressed
Hybridization of an adult mouse tissue Northern blot with an Evi5 3' UTR probe identi®ed an *6 kb transcript in all tissues analysed (Figure 7 ). This hybridization pattern was similar to that obtained previously with the mouse genomic probe S (Figure 1 ; data not shown). Evi5 is also expressed in the embryo where Evi5 transcripts could be detected in all embryonic stages examined (E7-E17, Figure 7) . Evi5 is thus widely expressed, at least at the RNA level, in both embryonic and adult mouse tissues. In vitro transcription and translation of a 2.9 kb Evi5 construct containing the entire Evi5 open reading frame produced a 90 kDa protein, which is the predicted size of the full-length Evi5 protein (Figure 8 ). Figure 4 Amino acid sequence comparison of the Evi5 tbc box with other tbc box-containing proteins. Alignment of the Evi5 (aa 169 ± 348) and Tbc1 tbc boxes was carried out using the PILEUP program provided by GCG (Devereux et al., 1984) . All other tbc boxes were aligned to the Tbc1 tbc box as described previously (Richardson and Zon, 1995) . Amino acid residues that were identical in three or more tbc box proteins are indicated in bold Evi5 homology to cell cycle regulators X Liao et al
Discussion
The Evi5 locus is a common site of viral integration in AKXD T-cell lymphomas (Liao et al., 1995a) . Mapping studies have localized this common site to a region approximately 18 kb upstream of another common viral integration site, G®1 (Liao et al., 1995a) . G®1 encodes a zinc ®nger transcription factor thought to be involved in IL-2 signaling (Gilks et al., 1993 ). An important question raised by these studies is whether viral integration at Evi5 merely serves to activate expression of the G®1 zinc ®nger gene or whether Evi5 encodes a separate disease-causing gene. In studies described here, we show that Evi5 does in fact encode a separate gene that is oriented in the same transcriptional direction as G®1 and is disrupted by viral integration at Evi5.
Evi5 is widely expressed in both embryonic and adult mouse tissues and is highly conserved throughout evolution suggesting that Evi5 serves an important function in the cell. Two Evi5-related loci that map to mouse chromosomes 10 and 18 were also identi®ed by chromosome mapping. Like Evi5, zoo blot analysis indicates that these two Evi5-related genes are well conserved throughout evolution indicating that they too may serve important functions in the cell.
Genomic analysis showed that the Evi5 common viral integration site is located within an intron in the Figure 5 Evi5 maps to mouse chromosome 5 while two Evi5-related loci map to chromosomes 10 and 18. The chromosomal location of Evi5 and two Evi5-related loci (Evi5-rs1 and Evi5-rs2) were determined by interspeci®c backcross analysis. The segregation patterns of the Evi5 loci and¯anking genes are shown at the top. For individual pairs of loci more animals than are shown in the haplotype analysis were often typed. These additional animals were used in calculating the recombination distances. Partial chromosome linkage maps showing the location of the Evi5 loci in relation to linked genes are shown at the bottom. Recombination distances between loci in centiMorgans (+ the standard error) are indicated to the left of each map. Where no recombinant animals were identi®ed the upper 95% con®dence limit of the distance between the loci is given in parentheses. Zoo blot analysis suggests a family of highly conserved Evi5-related genes. DNAs from a number of dierent species were hybridized at low stringency with an Evi5 coding region probe. (Robbins et al., 1992) and Int6 (Marchetti et al., 1995) . Such integrations could inactivate the gene or produce truncated protein products with altered biological activity. In the case of Myb and Tpl2, viral integrations are in the same transcriptional orientation as the gene and produce a truncated protein. These proteins are likely to be oncogenic as they lack negative regulatory domains located in the truncated sequences (Introna et al., 1994; Patriotis et al., 1994) . Viral integrations in Tiam1 and Int3 are also oriented in the same direction as the gene. However, instead of producing truncated proteins, novel 3' end products, which are initiated in viral 3' long terminal repeat (LTR) sequences, are produced. These 3' end products are also likely to be oncogenic (Jhappan et al., 1992; Robbins et al., 1992; Habets et al., 1994) . In contrast, Int6 integrations are in the opposite orientation as the gene and prematurely terminate Int6 transcripts due to a cryptic transcription stop signal present in the viral LTR. The biological signi®cance of this truncated transcript has not been determined. Like Int6, viral integrations at Evi5 are in the opposite transcriptional orientation as the gene. However, as RNA from the tumors with viral integrations at Evi5 is not available, it has not yet been possible to determine whether these viral integrations produce a truncated protein or suppress Evi5 expression. Experiments are in progress to identify additional tumors with viral integrations at Evi5 so that the aect of these integrations on Evi5 expression can be directly determined. BLAST searches indicated that Evi5 is a novel protein. A number of interesting homologies were detected, however, between Evi5 and known genes. Within the N-terminal half of Evi5 (aa 169 ± 348) a tbc box, a probable regulatory domain for protein-protein interactions, was identi®ed. Other tbc box-containing proteins include Tbc1, Tre2, cdc16 and BUB2.
The gene with the highest homology to Evi5 is Tbc1. While little is known about this protein, it has been shown to encode a nuclear protein that is dierentially expressed during mast cell dierentiation (Richardson and Zon, 1995) . Tbc1 may thus play a role in the mast cell dierentiation. The Tre2 oncogene was generated by DNA recombination during transfection of NIH3T3 cells with human Ewing's sarcoma DNA (Nakamura et al., 1988) . Tre2 has been proposed to function as a tumor suppressor by inhibiting protein degradation mediated by the ubiquitin/deubiquitin system (Natkamura et al., 1988 Papa and Hochstrasser, 1993) . A number of genes involved in growth control are short-lived and are regulated by protein degradation involving the ubiquitin/deubiquitin system. Tre2 could cause tumors by interfering with the degradation of these growth control proteins. cdc16, isolated from S. pombe (Frankhauser et al., 1993; Frankhauser and Simanis, 1994) , and BUB2, its functional homologue in S. cerevisiae (Hoyt et al., 1991; Wang and Burke, 1995) , are implicated in mitotic spindle checkpoint control. These genes are thought to achieve this control by checking on the state of mitotic spindle formation at the end of mitosis and, if not complete, arresting the cell in mitosis until spindle formation is complete. How this arrest is caused is not entirely clear but experiments suggest that arrest occurs by preventing the inactivation of the cdc2 mitotic kinase that normally is required for exit from mitosis (Hoyt et al., 1991; Frankhauser et al., 1993) .
The C-terminal half of Evi5 shows signi®cant homology to a number of coiled-coil proteins including mitosin, a protein involved in cell cycle control (Liao et al., 1995a; Zhu et al., 1995) . Mitosin is a *350 kDa nuclear phosphoprotein that is expressed only during the S and G 2 /M phases of the cell cycle. Mitosin undergoes a dynamic spatial reorganization to several components of the mitotic apparatus (e.g. the centromere and mitotic spindle) during M-phase progression and this redistribution coincides closely with changes in phosphorylation. Overexpression of Nterminally truncated mutants block cell cycle progression at G 2 /M suggesting that mitosin plays an important role in mitotic-phase progression.
Given the homology of Evi5 to known oncogenes and cell cycle regulators it is tempting to speculate that Evi5 is itself a T-cell disease gene involved in cell cycle control. This would not rule out the possibility that viral integration at Evi5 also serves a second purpose, namely, to activate expression of G®1. Consistent with this possibility, ZoÈ rnig and colleagues ZoÈ rnig et al., 1996) have recently shown that viral integration at Evi5 activates G®1 expression. It is thus possible that the Evi5 gene cooperates with G®1 in T-cell disease. Future studies involving transgenic mice may help resolve this question.
Materials and methods
Northern blot hybridization
RNA blots were purchased from Clontech Laboratories, Inc. (Palo Alto, CA). Northern blot hybridizations were performed as previously described (Church and Gilbert, 1984) . 
Southern blot hybridization
Southern blot hybridizations using 32 P-labeled oligonucleotide probes were performed under standard conditions (Maniatis et al., 1982) at 428C and washed at 428C with 46 SSC, 0.1% SDS. Zoo-blot cross species hybridization was performed as previously described (Gilbert et al., 1993) and the blots were washed at 658C with 46 SSC and 0.1% SDS.
Probes
Probe S, isolated from the 5' proviral-cellular junction of BXH-2 tumor 82-6 as described previously (Liao et al., 1995a) , was used for detecting Evi5 transcripts and for the initial cDNA library screening. cDNA clones S5A-1 (see Figure 2 ), S610-C and a 5' fragment, P7-U, of cDNA clone CP7 (see Figure 2) , were used for chromosomal mapping studies. S610-C, was a 1 kb cDNA clone of the 3' UTR of Evi5; P7-U was a 2.3 kb DNA fragment generated by EcoRI and XbaI double-digest of cDNA clone CP7. Probe P400 was a 400 bp PstI fragment of CP7 (bps 1449 ± 1899 of Evi5) and was used for Zoo-blot and Northern blot analysis. Three oligonucleotide probes were used for hybridization studies of lambda clones of the 3' genomic region of Evi5 to determine intron and exon regions: 5'-GATGCCTAAAAGGCCAGCGGG-3' (bps 2191 ± 2211); 5'-ATAGCAGAGCTGACTCATG-3' (bps 2166 ± 2184); and 5'-TCAGCTCTGCTATCTGG-3' (antisense, bps 2162 ± 2178).
Interspeci®c backcross mapping
Interspeci®c backcross progeny were generated by mating (C57BL/6J X Mus spretus)F 1 females and C57BL/6J males as described . A total of 205 N 2 mice were used to map the Evi5 and Evi5-related loci. DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, Southern blot transfer and hybridization were performed essentially as described (Jenkins et al., 1982) . All blots were prepared with Hybond-N + nylon membrane (Amersham). The probes (described above) were labeled with [a 32 P]dCTP by random priming (Stratagene); washing was done to a ®nal stringency of 0.16SSCP, 0.1% SDS, 658C. The P7-U probe detected major fragments of 14.0, 6.6, 5.0, 1.4, 1.0, 0.9 and 0.7 kb in PvuII-digested C57BL/6J DNA and 14.0, 6.6, 5.4, 2.4 and 1.5 kb in PvuIIdigested Mus. spretus DNA. The presence or absence of the 5.4, 2.4 and 1.5 kb Mus. spretus-speci®c PvuII fragments, which mapped to three dierent chromosomes, were followed in backcross mice.
A description of the probes and RFLPs for the loci linked to Evi5, Evi5-rs1 and Evi5-rs2 have been described. These loci include ®broblast growth factor 5 (Fgf5), growth factor independence 1 (G®1) and crystallin beta B2 (Crybb2) on chromosome 5 (Benovic et al., 1991; Bell et al., 1995; Hulsebos et al., 1995) ; interferon gamma (Igf), glioma associated oncogene (Gli) and avian erythroblastosis oncogene B3 (Erbb3) on chromosome 10 (Justice et al., 1990; Copeland et al., 1995) ; and tumor progression locus 2 (Tpl2) and cadherin 2 (Cdh2) on chromosome 18 (Justice et al., 1992; Miyatani et al., 1992) . Recombination distances were calculated as described (Green, 1981) using the computer program SPRETUS MADNESS. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
cDNA libraries and screenings cDNA clones of Evi5 were isolated from two cDNA libraries. The ®rst one is a Stratagene (La Jolla, CA) premade, oligo dT-primed mouse liver cDNA library (#935302). The second one is a C57BL/6J mouse liver cDNA library constructed by Stratagene custom library service using random primers (Stratagene) and an Evi5 antisense primer, 5A (bps 1514 ± 5132 of Evi5), derived from the 5' end of sequence of Evi5 cDNA clone cp7: 5'-CACTTTATCCTGCATCTCC-3'. Plaque hybridizations were performed under the standard conditions (Maniatis et al., 1982) .
DNA sequencing
Both strands of cDNA clones were sequenced by the Sanger method of dideoxynucleotide chain termination reactions (Sanger et al., 1977) , using a Sequenase Kit (USB).
Ligation-mediated 5' RACE
The 5'-end clone of Evi5 cDNA was obtained by 5' RACE (rapid ampli®cation of cDNA ends), using a 5'-AmpliFINDER RACE kit (Clontech) and two nested antisense Evi5 primers derived from the 5'-end sequence of cDNA clone S5A-1, 90R: 5'-TGATACAAGAGAG-GAACC-3', (bps 413 ± 430 of Evi5 cDNA) and 70R: 5'-ACCACTGTTTCTTCTTGACC-3', (bps 396 ± 415 of Evi5 cDNA). PolyA-selected RNA was extracted from livers of 6 weeks old C57BL/6J mice using a mRNA isolation kit (Stratagene). 90R was used for synthesis of the ®rst strand of cDNA; primer 70R and the 5'-AmpliFINDER anchor primer were used for the ampli®cation of the RACE fragment of 5' end of the Evi5 cDNA. The PCR product was cloned into PCR-script vector (Stratagene), which was designated cDNA clone R-6 (see Figure 2 ).
Computer analysis
The software package of the Genetic Computer Group (GCG, Devereux and Smithies, 1984) was used for analysis of Evi5 sequences. The open reading frame of Evi5 was identi®ed by using the program Frames. Database search on the level of both nucleotide and protein was performed by the Blast program of National Center for Biological Information, and GCG program Fasta and Tfasta. The potential amino acid modi®cations, such as glycosylation and phosphorylation, of Evi5 protein was identi®ed by GCG program Motifs.
Genbank accession number
U53586.
Construction and in vitro expression of Evi5 vector
A full length Evi5 open reading frame expression vector, Evi5p2914, was constructed by subcloning 1-2914 nt of Evi5 cDNA into an eucaryotic expression vector pCR3 (Invitrogen). The Evi5 fragment was generated by a 2-step PCR which linked Evi5 cDNA plasmids R-6 and S5-1A (see Figure 2 ) (using PCR primer of Evi5 5' UTR: 5'-TCTCCTCCTCTCATCATGG-3' (bps 54 ± 72 of Evi5 cDNA), and an antisense primer: 5'-TTTCAATGCGC-TGTTTTAAAAGCCTA-3' (bps 1405 ± 1431 of Evi5 cDNA) with CP7 (using the same 5' UTR primer and an antisense primer: 5'-AGACATGCCAAGCACAGG-3' (bps 2897 ± 2914 of Evi5 cDNA). The predicted stop codon for the Evi5 open reading resides at bps 2496 ± 2498. PCR reactions were performed for 30 cycles at the conditions of 948C, 1 min; 558C, 1 min and 728C, 3 min using Taq polymerase (Gibco/BRL). The Evi5 expression vector was sequenced at regions¯anking PCR primers to ensure accuracy. In vitro expression studies were performed by using the TNT Coupled Reticulocyte Lysate Systems Evi5 homology to cell cycle regulators X Liao et al (Promega) with [ 35 S]Methionine and T7 RNA polymerase, following the manufacturer's protocol. The translation products were separated on a 4 ± 15% glycine gel (BioRad) and analysed by autoradiography and Western blot analysis.
